Trial Profile
A Randomized, Double-Blind Comparison of Duloxetine 30 mg QD and Placebo in Adult Patients With Fibromyalgia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2012
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 11 Sep 2012 Results published in the Clinical Journal of Pain.
- 09 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 07 Dec 2010 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.